AZYO

Aziyo Biologics Inc.

Price

return (12m)

p/e

-0.67

p/bv

-0.95

DIVIDEND YIELD

0.00%

AZYO price

Aziyo Biologics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AZYO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals AZYO

Valuation

P/E

-0.67

Sector -4.26

Industry -4.26

P/BV

-0.95

Sector 2.11

Industry 2.11

P/Revenue (PSR)

0.42

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

-1.10

Sector -50.76

Industry -50.76

P/EBIT

-0.88

Sector -39.62

Industry -39.62

P/Total Assets

0.51

Sector 1.25

Industry 1.25

P/Net Current Assets

Sector -5.47

Industry -5.47

P/Working Capital

Sector -1.10

Industry -1.10

EPS

-2.46

Sector -1.94

Industry -1.94

BVPS

-1.73

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

36.71%

Sector 38.90%

Industry 38.90%

EBITDA Margin

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

0.00%

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

-67.77%

Sector -36.74%

Industry -36.74%

Net Profit Margins

-63.22%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.11

Sector 0.03

Industry 0.03

Profitability

ROE

142.14%

Sector -61.50%

Industry -61.50%

ROA

-76.76%

Sector -63.85%

Industry -63.85%

ROIC

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

Sector -0.60

Industry -0.60

Gross Debt / Equity

Sector -0.83

Industry -0.83

Equity/Assets

-0.54

Sector 0.43

Industry 0.43

Liabilities/Assets

-0.54

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

22.79%

Sector -

Industry -

5Y Earnings CAGR

11.03%

Sector -

Industry -

Fundamentals AZYO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AZYO Aziyo Biologics Inc.	$0.00	-	0.00%	-0.67	-0.95	142.14%	-63.22%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AZYO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Aziyo Biologics

Aziyo Biologics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

11 years

Founded: 2015

2020

Time since IPO - 6 years

163

Employees

Aziyo Biologics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $27.91 million, with shareholders equity totaling $-29.47 million.

The company employs approximately 163 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Aziyo Biologics Inc. reported $66.27 million in revenue, generating net income of $-41.89 million.

Key financial metrics include a P/E ratio of -0.67, a price-to-book (P/B) ratio of -0.95, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AZYO.

Market cap

$27.91 million

Net worth

$-29.47 million

$-29,473,000.00

Assets

$54.58 million

$54,580,000.00

Total Shares Outstanding

17.02 million

17,017,000

Average Daily Trading Volume

$557.57 Thousand

$557,572.86

Sector

Health Care

Industry

Biotechnology

AZYO

AZYO revenue and profits

Financial Results AZYO

DRAG THE FRAME TO SEE MORE DATA

AZYO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Aziyo Biologics (AZYO) today?

A cotação de Aziyo Biologics (AZYO) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Aziyo Biologics (AZYO) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Aziyo Biologics (AZYO) e dados de ações do Ibovespa e mercados internacionais.

Quando Aziyo Biologics (AZYO) paga dividendos?

Aziyo Biologics (AZYO) não distribuiu dividendos no último ano.

Is Aziyo Biologics (AZYO) a good investment?

Atualmente, Aziyo Biologics (AZYO) está cotada a US$ 0.00, com um P/L de -0.67, representando um desvio de -92% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Aziyo Biologics (AZYO) stock?

Investir em ações de Aziyo Biologics (AZYO) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Aziyo Biologics (AZYO) yield today?

A rentabilidade de Aziyo Biologics (AZYO) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Aziyo Biologics (AZYO) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

AZYO

Aziyo Biologics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment AZYO

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING AZYO WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Aziyo Biologics

Aziyo Biologics Inc.

United States

11 years

2020

163

PROFIT X PRICE AZYO

Financial Results AZYO

AZYO cash flow

Asset, Revenue and Profit Growth - AZYO

AZYO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions